Commonwealth Bank of Australia (CBA), the nation’s largest lender, reported a slight rise in first-half profit, driven by economic recovery and a significant drop in loan impairment charges. The bank’s shares hit a record high following the announcement.
CBA’s cash net profit increased 2% to A$5.1 billion ($3.2 billion) for the six months ending December, slightly surpassing market expectations. The 23% decline in loan impairment charges provided a crucial boost, as profits would have remained nearly flat otherwise. Despite ongoing cost-of-living challenges, the bank noted a 15% drop in loan hardship cases, with most borrowers staying ahead on repayments.
CEO Matt Comyn anticipates Australia will begin an easing cycle in 2025, mirroring global economies. This, he believes, will alleviate financial pressure on households and bolster business confidence.
CBA declared its highest-ever interim dividend of A$2.25 per share, up from A$2.15 a year ago. The bank’s shares surged 1% to an intraday high of A$164.71, extending a strong rally that has made it Australia’s largest company by market capitalization. The broader market edged up 0.2%.
Despite the positive results, Citi analysts noted that the performance aligned with market expectations and did not necessarily justify the recent share price surge.
CBA, which controls a quarter of Australia’s A$2.2 trillion mortgage market, saw a 6% rise in costs as it invested in technology and AI infrastructure. The lender’s net interest margin improved by 2 basis points to 2.08%.
With rising wages and tax cuts boosting savings and spending, CBA remains optimistic about economic resilience despite inflationary pressures.


Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links 



